title: Characterization of the transport properties of organic anion transporting polypeptide 1 (oatp1) and Na(+)/taurocholate cotransporting polypeptide (Ntcp): comparative studies on the inhibitory effect of their possible substrates in hepatocytes and cDNA-transfected COS-7 cells.
abstract: In the present study, we compared the inhibitory effects of organic anions (including bile acids) on the uptake of taurocholate (TC) and estradiol 17beta-D-glucuronide (E(2)17betaG), typical substrates for sodium taurocholate cotransporting polypeptide (Ntcp) and organic anion transporting polypeptide (oatp1), respectively, using primary cultured rat hepatocytes and Ntcp- or oatp1-transfected COS-7 cells. The Na(+)-dependent uptake of TC was inhibited by nine bile acids and five nonbile acid organic anions in a concentration-dependent manner, and their inhibitory effects were similar in both primary cultured rat hepatocytes and Ntcp-transfected COS-7 cells. BQ-123 (1 microM) and indomethacin (10 microM), both of which exhibit no Ntcp-mediated transport, significantly inhibited the Na(+)-dependent uptake of TC mediated by Ntcp. In addition, the Na(+)-independent uptake of E(2)17betaG was inhibited by 15 organic anions in a concentration-dependent manner, and their inhibitory effects were similar between primary cultured rat hepatocytes and oatp1-transfected COS-7 cells. BQ-123 (1 microM), pravastatin (1 microM), and indomethacin (10 microM), all of which do not undergo oatp1-mediated transport, significantly inhibited the Na(+)-independent uptake of E(2)17betaG mediated by oatp1. These results are consistent with the hypothesis that the hepatic uptake of TC and E(2)17betaG is predominantly mediated by Ntcp and oatp1, respectively. In addition, it was clearly demonstrated that we cannot refer to the substrate specificity of transporters based on inhibition studies.
authors.affiliation: Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Kouzuki
authors.forename: H
authors.initials: H
authors.lastname: Suzuki
authors.forename: B
authors.initials: B
authors.lastname: Stieger
authors.forename: P J
authors.initials: PJ
authors.lastname: Meier
authors.forename: Y
authors.initials: Y
authors.lastname: Sugiyama
mesh_terms: D000818:Animals; D027321:Anion Transport Proteins; D019556:COS Cells; D002352:Carrier Proteins / Q000494:pharmacology*; D002478:Cells, Cultured; D018076:DNA, Complementary; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D004958:Estradiol / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D007213:Indomethacin / Q000494:pharmacology; D026901:Membrane Transport Proteins; D029363:Organic Anion Transporters, Sodium-Dependent; D010456:Peptides, Cyclic / Q000494:pharmacology; D051381:Rats; D012964:Sodium / Q000502:physiology; D027981:Symporters; D013656:Taurocholic Acid / Q000493:pharmacokinetics*; D014162:Transfection
chemical_list: D027321:Anion Transport Proteins; D002352:Carrier Proteins; D018076:DNA, Complementary; D026901:Membrane Transport Proteins; D029363:Organic Anion Transporters, Sodium-Dependent; D010456:Peptides, Cyclic; D027981:Symporters; C071908:sodium-bile acid cotransporter; C025483:estradiol-17 beta-glucuronide; D004958:Estradiol; D013656:Taurocholic Acid; D012964:Sodium; C072247:cyclo(Trp-Asp-Pro-Val-Leu); D007213:Indomethacin